50 ML argatroban 1 MG/ML Injection — RxCUI 1804735
RxNorm drug concept · Semantic clinical drug
RxCUI 1804735
Semantic clinical drug · SCD
● Current RxNorm concept 11 FDA products
13 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1804735
Official name50 ML argatroban 1 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asargatroban 50 MG per 50 ML Injection; argatroban 50 MG in 50 ML Injection
FDA products mapped11
Package NDCs mapped13
Reported Medicaid activity (SDUD)69 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Argatroban: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Argatroban is used when heparin has caused a serious reaction called heparin-induced thrombocytopenia, or HIT. In HIT, your immune system reacts to heparin in a way that actually t...
- Why am I getting argatroban instead of regular heparin?
- Yes, you'll be awake. Argatroban is given as a slow, continuous drip through an IV line directly into your vein. It's always given in a hospital or clinical setting by your care te...
- How will I receive argatroban, and will I be awake during treatment?
🕸️ Concept Web — How 50 ML argatroban 1 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
50 ML argatroban 1 MG/ML Injection
RxCUI 1804735 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Argatroban
15202IN
-
Argatroban
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Argatroban Injection
1804730SCDF -
Argatroban Injectable Product
1158258SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Argatroban Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Argatroban 1 MG/ML
1110707SCDC
-
Argatroban 1 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Argatroban 1 MG/ML
SCDC · 1110707 -
Argatroban Injection
SCDF · 1804730 -
Argatroban Injectable Product
SCDG · 1158258
📦 FDA Products & Package NDCs
11 products · 13 package NDCs
13 package NDCs map to RxCUI 1804735 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9377-01 | 1 VIAL in 1 CARTON (0143-9377-01) / 50 mL in 1 VIAL | Argatroban | Hikma Pharmaceuticals USA Inc. | 2020-03-25 |
| 00143-9559-01 | 1 VIAL in 1 CARTON (0143-9559-01) / 50 mL in 1 VIAL | Argatroban | Hikma Pharmaceuticals USA Inc. | 2016-11-01 |
| 00143-9674-01 | 2.5 mL in 1 VIAL (0143-9674-01) | Argatroban | Hikma Pharmaceuticals USA Inc. | 2012-01-05 |
| 16729-0430-11 | 1 VIAL, SINGLE-USE in 1 CARTON (16729-430-11) / 50 mL in 1... | ARGATROBAN | Accord Healthcare Inc. | 2021-10-07 |
| 16729-0430-43 | 10 VIAL, SINGLE-USE in 1 CARTON (16729-430-43) / 50 mL in 1... | ARGATROBAN | Accord Healthcare Inc. | 2021-10-07 |
| 25021-0414-50 | 1 VIAL in 1 CARTON (25021-414-50) / 50 mL in 1 VIAL | Argatroban | Sagent Pharmaceuticals | 2021-04-15 |
| 55150-0241-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-241-01) / 50 mL in 1... | Argatroban | Eugia US LLC | 2018-11-27 |
| 55150-0241-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-241-10) / 50 mL in... | Argatroban | Eugia US LLC | 2018-11-27 |
| 65145-0126-01 | 1 VIAL in 1 CARTON (65145-126-01) / 50 mL in 1 VIAL | ARGATROBAN | Caplin Steriles Limited | 2026-04-17 |
| 65219-0429-50 | 1 VIAL in 1 CARTON (65219-429-50) / 50 mL in 1 VIAL | Argatroban | Fresenius Kabi USA, LLC | 2021-05-24 |
| 68083-0568-01 | 1 VIAL in 1 CARTON (68083-568-01) / 50 mL in 1 VIAL | Argatroban | Gland Pharma Limited | 2023-07-31 |
| 83301-0062-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83301-0062-1) / 50 mL in 1... | Argatroban | Mullan Pharmaceutical Inc. | 2026-03-10 |
| 83301-0500-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83301-0500-1) / 50 mL in 1... | Argatroban | Mullan Pharmaceutical Inc. | 2026-01-01 |
Observed labelers:
Hikma Pharmaceuticals USA Inc. (3) ·
Accord Healthcare Inc. (2) ·
Eugia US LLC (2) ·
Mullan Pharmaceutical Inc. (2) ·
Caplin Steriles Limited (1) ·
Fresenius Kabi USA, LLC (1)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0883 | Argatroban nonesrd use 1mg | 7 | CMS |
| J0884 | Argatroban esrd dialysis 1mg | 7 | CMS |
| J0898 | Argatroban nonesrd (auromed) | 2 | CMS |
| J0899 | Argatroban dialysis, auromed | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.